[Tickers Inside] 7 Solid Gainers Over the Last 5 Sessions

Stocks with 5 days of consecutive price advances. If you cannot see this email properly, please click [here]( [marketticker...] --------------------------------------------------------------- Sponsor Message [Copper Exploration Heating Up]( [Discover the Opportunities in the New Copper Hotspot]([aff_i?offer_...] --------------------------------------------------------------- November 14, 2022 From the desk of the Editor (5 Day Gainers Report) Dear Reader, We just identified 7 Five Day Gainers across all US Exchanges. If you are interested in any of these companies, we encourage you to do your own research and due diligence. Keep reading to see what we just uncovered... --------------------------------------------------------------- Sponsor Message [Huge Upside Potential With "Staggering" Solar Demand]( [bf8c887b-c2f...](Global solar demand is "staggering" right now, according to Bloomberg. Solar installations are set to grow 30% this year alone. And the boom is just beginning, with increasing adoption of solar by commercial, non-profit, and public entities. With only 1% of commercial electricity demand served by on-site solar globally, there is HUGE opportunity for growth. [See How Investors Could Benefit]( [5381a560-c43...]([aff_i?offer_...] --------------------------------------------------------------- [Adaptimmune Therapeutics, ADAP]( Recent Analyst Action: Mara Goldstein, analyst at Mizuho Securities, reiterates coverage on [Adaptimmune Therapeutics (ADAP)](in the Healthcare sector with a Buy rating and a price target of $9.00 (5 days ago). - Recent Price: $2.495 - Average Analyst Price Target: $5.70 (128.46%) - Market Cap: $410.06M [TipRanks.com]( also reports that [Adaptimmune Therapeutics](currently has 5 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $5.70. The target pricing ranges from a high forecast of $10.00 down to a low forecast of $1.50. [Adaptimmune Therapeutics (ADAP)](’s last closing price was $2.495 which would put the average price target at $5.70. Here are 3rd party ratings for [ADAP](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak buy - Zacks.com: Buy, Top 24% (61 out of 252) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [These 2 Dividend Stocks Pay Every Week]( [bc82e8e3-d6f...](Are you still looking for consistent income in this near-zero interest rate environment? There is a better way. I just revealed the Holy Grail of dividend stocks - a safe, reliable and consistent stock that [pays dividends EVERY single week](- 52 times a year. It's simple: Buy the stock this Monday and you'll get your first dividend payout in your bank account this Thursday....and then every Thursday after for as long as you own the stock! [Tap here to reveal the name of this stock for FREE.]( [5381a560-c43...]( [aff_i?offer_...] --------------------------------------------------------------- [Flux Power Holdings, FLUX]( Recent Analyst Action: Amit Dayal, analyst at H.C. Wainwright, reiterates coverage on [Flux Power Holdings (FLUX)](in the Services sector with a Buy rating and a price target of $15.00 (3 days ago). - Recent Price: $5.257 - Average Analyst Price Target: $10.50 (99.75%) - Market Cap: $75.51M [TipRanks.com]( also reports that [Flux Power Holdings](currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $10.50. The target pricing ranges from a high forecast of $15.00 down to a low forecast of $6.00. [Flux Power Holdings (FLUX)](’s last closing price was $5.257 which would put the average price target at $10.50. Here are 3rd party ratings for [FLUX](: - TipRanks.com: Moderate Buy - TradingView.com: Strong Buy - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Buy, Top 35% (89 out of 252) [Click here for chart >>]( -------------------------------------------------------------------------- [Recursion Pharmaceuticals, RXRX]( Recent Analyst Action: Salveen Richter, analyst at Goldman Sachs, reiterates coverage on [Recursion Pharmaceuticals (RXRX)](in the Healthcare sector with a Hold rating and a price target of $9.00 (5 days ago). - Recent Price: $13.07 - Average Analyst Price Target: $17.20 (31.60%) - Market Cap: $2.37B [TipRanks.com]( also reports that [Recursion Pharmaceuticals](currently has 5 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $17.20. The target pricing ranges from a high forecast of $38.00 down to a low forecast of $9.00. [Recursion Pharmaceuticals (RXRX)](’s last closing price was $13.07 which would put the average price target at $17.20. Here are 3rd party ratings for [RXRX](: - TipRanks.com: Moderate Buy - TradingView.com: Strong Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Sell, Top 35% (89 out of 252) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message Market Wizard who predicted all indexes would be negative in 2022 shares shocking new forecast: ["Prepare for Five Years of Famine"]( [Screen+Shot+...]( [Click here]( for the name of the one ticker you need to protect yourself.[5381a560-c43...]([aff_i?offer_...] --------------------------------------------------------------- [Shift4 Payments, FOUR]( Recent Analyst Action: Daniel Perlin, analyst at RBC Capital, reiterates coverage on [Shift4 Payments (FOUR)](in the Services sector with a Buy rating and a price target of $57.00 (6 days ago). - Recent Price: $48.34 - Average Analyst Price Target: $54.22 (12.16%) - Market Cap: $3.81B [TipRanks.com]( also reports that [Shift4 Payments](currently has 9 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $54.22. The target pricing ranges from a high forecast of $65.00 down to a low forecast of $32.00. [Shift4 Payments (FOUR)](’s last closing price was $48.34 which would put the average price target at $54.22. Here are 3rd party ratings for [FOUR](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak buy - Zacks.com: Buy, Bottom 39% (153 out of 252) [Click here for chart >>]( -------------------------------------------------------------------------- [Life Time Group Holdings, LTH]( Recent Analyst Action: Chris Woronka, analyst at Deutsche Bank, reiterates coverage on [Life Time Group Holdings (LTH)](in the Services sector with a Buy rating and a price target of $17.00 (3 days ago). - Recent Price: $12.21 - Average Analyst Price Target: $15.50 (26.95%) - Market Cap: $2.37B [TipRanks.com]( also reports that [Life Time Group Holdings](currently has 6 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $15.50. The target pricing ranges from a high forecast of $18.00 down to a low forecast of $12.00. [Life Time Group Holdings (LTH)](’s last closing price was $12.21 which would put the average price target at $15.50. Here are 3rd party ratings for [LTH](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: sell - Zacks.com: Hold, Top 50% (127 out of 252) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [How High Can Copper Go?]( [c822a1ed-f3f...](To power the green revolution, copper demand continues to skyrocket with no end in sight. Prices hit a 10-year high; as copper jumped 79% in the past year. Some analysts are calling for copper to rise another 50-100%! We may be at the beginning of a copper bull run the likes we've never seen before. Just how high can copper go? [Find Out in this Research Report.]( [5381a560-c43...]([aff_i?offer_...] --------------------------------------------------------------- [Sleep Number, SNBR]( Recent Analyst Action: Seth Basham, analyst at Wedbush, reiterates coverage on [Sleep Number (SNBR)](in the Consumer Goods sector with a Hold rating and a price target of $27.00 (2 weeks ago). - Recent Price: $34.195 - Average Analyst Price Target: $26.50 (-22.50%) - Market Cap: $728.23M [TipRanks.com]( also reports that [Sleep Number](currently has 2 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $26.50. The target pricing ranges from a high forecast of $27.00 down to a low forecast of $26.00. [Sleep Number (SNBR)](’s last closing price was $34.195 which would put the average price target at $26.50. Here are 3rd party ratings for [SNBR](: - TipRanks.com: Hold - TradingView.com: Buy - Yahoo! Finance: Neutral Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Strong Sell, Bottom 20% (201 out of 252) [Click here for chart >>]( -------------------------------------------------------------------------- [BioVie, BIVI]( Recent Analyst Action: Constantine Davides, analyst at EF Hutton, reiterates coverage on [BioVie (BIVI)](in the Healthcare sector with a Buy rating and a price target of $8.00 (1 month ago). - Recent Price: $5.02 - Average Analyst Price Target: $10.00 (99.20%) - Market Cap: $154.80M [TipRanks.com]( also reports that [BioVie](currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $10.00. The target pricing ranges from a high forecast of $12.00 down to a low forecast of $8.00. [BioVie (BIVI)](’s last closing price was $5.02 which would put the average price target at $10.00. Here are 3rd party ratings for [BIVI](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Buy, Top 35% (89 out of 252) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [New "Vertical" Technology Solves Solar Power's Major Flaw]( [43705a26-d32...](Even conservationists hate conventional solar farms. That's because they take up too much land and can degrade the environment. And let's face it, land is expensive... Fortunately, new groundbreaking tower technology solves solar's #1 drawback. These unique vertical structures not only take up to 90% less land space, but also generate extra electric power. [See How Early Stage Investors in This Solar Tech Could Benefit]( [5381a560-c43...]([aff_i?offer_...] --------------------------------------------------------------- And there you have it--7 Five Day Gainers across all US Exchanges. Sincerely, The Editor, MarketTickerPress.com Market Ticker Press Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. By opening and/or clicking a link containted within this email, you are reconfirming your opt-in status. You can unsubscribe at any time. MarketTickerPress.com part of Sandpiper Marketing Group | 1519 Mecklenburg Hwy | Unit 4 | Mt. Mourne | North Carolina | 28123 | United States | 877-411-9808 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software